Aigen Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,325
| Closed | -$31.8K | – | 806 |
|
|
2024
Q1 | $31.8K | Buy |
+13,325
| New | +$31.8K | 0.01% | 637 |
|
|
2021
Q2 | – | Sell |
-46,735
| Closed | -$683K | – | 510 |
|
|
2021
Q1 | $683K | Buy |
46,735
+21,396
| +84% | +$313K | 0.09% | 236 |
|
|
2020
Q4 | $440K | Buy |
25,339
+6,156
| +32% | +$107K | 0.06% | 427 |
|
|
2020
Q3 | $352K | Sell |
19,183
-14,931
| -44% | -$274K | 0.04% | 492 |
|
|
2020
Q2 | $609K | Buy |
+34,114
| New | +$609K | 0.08% | 402 |
|